Literature DB >> 21920917

Atrial fibrillation and mortality in heart failure: a community study.

Alanna M Chamberlain1, Margaret M Redfield, Alvaro Alonso, Susan A Weston, Véronique L Roger.   

Abstract

BACKGROUND: Heart failure (HF) and atrial fibrillation (AF) share common risk factors and often coexist. The combination of HF and AF may carry a worse prognosis than either condition alone; however, the magnitude of this risk remains controversial and it is not known whether the timing of AF influences the risk of death. METHODS AND
RESULTS: We determined the risk of all-cause mortality in relation to the presence of AF prior to or after HF diagnosis in a community-based cohort of persons diagnosed as having HF between 1983 and 2006. Of 1664 individuals with HF, 553 had a history of AF and 384 developed AF after HF. During a median follow-up of 4.0 years, 450 deaths occurred among persons with prior AF, 314 among those with AF after HF, and 572 among patients without AF. In fully adjusted models, compared with patients without AF, those with AF prior to HF had a 29% increased risk of death, whereas those who developed AF after HF exhibited >2-fold increased risk of death.
CONCLUSIONS: In the community, AF is frequent in the setting of HF and is associated with a large excess risk of death. The magnitude of this excess risk differs markedly according to the timing of AF, with AF developing after HF conferring the largest increased risk of death compared with HF patients without AF.

Entities:  

Mesh:

Year:  2011        PMID: 21920917      PMCID: PMC3222889          DOI: 10.1161/CIRCHEARTFAILURE.111.962688

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  33 in total

1.  Incident atrial fibrillation and mortality in older adults with heart failure.

Authors:  Ali Ahmed; Gilbert J Perry
Journal:  Eur J Heart Fail       Date:  2005-12       Impact factor: 15.534

Review 2.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

Review 3.  Diagnostic criteria for diastolic heart failure.

Authors:  R Frederick Yturralde; William H Gaasch
Journal:  Prog Cardiovasc Dis       Date:  2005 Mar-Apr       Impact factor: 8.194

4.  Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

Authors:  Karl Swedberg; Lars G Olsson; Andrew Charlesworth; John Cleland; Peter Hanrath; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip Poole-Wilson
Journal:  Eur Heart J       Date:  2005-03-14       Impact factor: 29.983

5.  Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

Authors:  H J Crijns; G Tjeerdsma; P J de Kam; F Boomsma; I C van Gelder; M P van den Berg; D J van Veldhuisen
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

6.  The definition of anemia in older persons.

Authors:  G J Izaks; R G Westendorp; D L Knook
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Trends in heart failure incidence and survival in a community-based population.

Authors:  Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

Review 9.  Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment.

Authors:  E Kevin Heist; Jeremy N Ruskin
Journal:  Prog Cardiovasc Dis       Date:  2006 Jan-Feb       Impact factor: 8.194

10.  Coronary disease surveillance in Olmsted County objectives and methodology.

Authors:  Véronique L Roger; Jill Killian; Mary Henkel; Susan A Weston; Tauqir Y Goraya; Barbara P Yawn; Thomas E Kottke; Robert L Frye; Steven J Jacobsen
Journal:  J Clin Epidemiol       Date:  2002-06       Impact factor: 6.437

View more
  49 in total

1.  Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation.

Authors:  Juntuo Zhou; Lijie Sun; Liwen Chen; Shuwang Liu; Lijun Zhong; Ming Cui
Journal:  Metabolomics       Date:  2019-06-21       Impact factor: 4.290

2.  Use of novel oral anticoagulants in patients with heart failure.

Authors:  Eduard Shantsila; Gregory Y H Lip
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

Review 3.  Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.

Authors:  Bharathi Upadhya; Dalane W Kitzman
Journal:  Am J Cardiovasc Drugs       Date:  2017-08       Impact factor: 3.571

4.  Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2016-05-25       Impact factor: 8.082

5.  Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Authors:  Stephen J Greene; Gregg C Fonarow; Scott D Solomon; Haris P Subacius; Andrew P Ambrosy; Muthiah Vaduganathan; Aldo P Maggioni; Michael Böhm; Eldrin F Lewis; Faiez Zannad; Javed Butler; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2016-10-17       Impact factor: 15.534

Review 6.  Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis.

Authors:  Pavlos G Myserlis; Antonia Malli; Dimitrios K Kalaitzoglou; Grigorios Kalaitzidis; Michael Miligkos; Damianos G Kokkinidis; Andreas P Kalogeropoulos
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 7.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

8.  Prognostic Impact of Chronic Kidney Disease in Patients with Heart Failure.

Authors:  Nektar Nikki Hakopian; Derenik Gharibian; Marlene M Nashed
Journal:  Perm J       Date:  2019-09-05

Review 9.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

10.  Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Pamela L Lutsey; Alvaro Alonso; Erin D Michos; Laura R Loehr; Brad C Astor; Josef Coresh; Aaron R Folsom
Journal:  Am J Clin Nutr       Date:  2014-07-16       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.